H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Vical Inc (NASDAQ: VICL) today and set a price target of $3.50. The company’s shares closed yesterday at $1.26.
Selvaraju said:
“Valuation methodology, risks and uncertainties. We employ a discounted cash flow (DCF)-based approach to valuing Vical, which drives a total risk-adjusted net present value (NPV) of roughly $100M, or a price per share of $3.50, assuming 29M fully-diluted shares outstanding at end-3Q19.”
According to TipRanks.com, Selvaraju has 0 stars on 0-5 star ranking scale with an average return of -14.6% and a 23.9% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Biospecifics Technologies Corp, Synergy Pharmaceuticals Inc, and Bausch Health Companies Inc.
Vical Inc has an analyst consensus of Moderate Buy, with a price target consensus of $3.50.
See today’s analyst top recommended stocks >>
The company has a one-year high of $2.24 and a one-year low of $1.02. Currently, Vical Inc has an average volume of 75.85K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. It has active development programs which comprises of ongoing phase 2 trial of HSV-2 therapeutic vaccine, VCL-HB01, to treat patients with symptomatic genital herpes infection; ongoing phase 2 trial of novel antifungal VL-2397, for the treatment of patients with invasive aspergillosis; and early stage development program of a novel treatment for chronic hepatitis B virus (CHB) infection based on its DNA and lipid-delivery technologies. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.
